Results 221 to 230 of about 98,296 (378)

The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose. [PDF]

Osteoporos Int
Konstantelos N, Kim S, Cheung AM, Burden AM, Grootendorst P, Cadarette SM.   +5 more
europepmc   +1 more source

Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line [PDF]

, 2001
Peter S. Mackie, Jane Fisher, Hong Zhou, Peter Choong   +3 more
openalex   +1 more source

Anticancer Activity of Polyoxometalate-Bisphosphonate Complexes: Synthesis, Characterization, In Vitro and In Vivo Results.

Inorganic Chemistry, 2017
A. Boulmier, Xinxin Feng, O. Oms, P. Mialane, E. Rivière, Christopher J. Shin, Jiaqi Yao, T. Kubo, T. Furuta, E. Oldfield, A. Dolbecq   +10 more
semanticscholar   +1 more source

Nitrate Prevents Sjögren's Disease by Modulating T Helper Cells via NF‐κB Pathway Suppression

Oral Diseases, EarlyView.
ABSTRACT Objective Sjögren's disease (SjD) is a chronic autoimmune disease characterized by abnormal T helper (Th) cell distribution in the salivary glands (SGs). Although nitrate can regulate immune responses and preserve SGs function, its preventive effects on SjD remain unexplored.
Conglin Du, Zi Yang, Yang Yang, Chunmei Zhang, Hideaki Kagami, Xianqi Li, Liang Hu, Junji Xu, Jian Zhou   +8 more
wiley   +1 more source

Long-Term Follow-Up of a Patient with McCune-Albright Syndrome: A Case Report. [PDF]

J Clin Med
Shoji Y, Kusaka S, Kawashima K, Hamaguchi S, Tachikake M, Akitomo T, Nomura R.   +6 more
europepmc   +1 more source

The Amino Bisphosphonate Ibandronate Prevents Vitamin D Toxicity and Inhibits Vitamin D-Induced Calcification of Arteries, Cartilage, Lungs and Kidneys in Rats [PDF]

, 2001
Paul A. Price, Jessica R. Buckley, Matthew K. Williamson   +2 more
openalex   +1 more source

Radiographic Analysis of MRONJ in Osteoporotic and Oncologic Patients on Bisphosphonates or Denosumab

Oral Diseases, EarlyView.
ABSTRACT Introduction Medication‐Related Osteonecrosis of the Jaw (MRONJ) is a severe adverse effect of antiresorptive and antiangiogenic treatment, primarily in osteoporotic and oncologic patients. The disease is characterized by persistent jawbone necrosis that results in significant impairment of the quality of life of involved patients.
Omar Ghanaiem, Gavriel Chaushu, Daya Masri   +2 more
wiley   +1 more source

Storage and Loss Moduli of Bone in Osteogenesis Imperfecta (OI) [PDF]

, 2012
Albert, Carolyne, Harris, Gerald F., Jameson, John, Smith, Peter A., Toth, Jeffrey   +4 more
core   +1 more source

Sclerostin antibody treatment enhances rotator cuff tendon-to-bone healing in an animal model [PDF]

, 2017
Alfredson, Black, Bone, Cadet, Chouinard, Colvin, Ditsios, Galatz, Galatz, Galatz, Genin, Gimbel, Ide, Ioannis Kormpakis, Keener, Kennel, Killian, Killian, Komori, Leesa M. Galatz, Leppälä, Li, Li, Li, Lipner, Manning, McClung, Michael S. Ominsky, Nakashima, Necat Havlioglu, Ominsky, Padhi, Schwartz, Schwartz, Shivam A. Shah, Silva, Sinder, Stavros Thomopoulos, Taylor, Thomopoulos, Thomopoulos, Thomopoulos, Thomopoulos, Tian, Veverka, West   +45 more
core   +3 more sources

Preadmission Bisphosphonate and Mortality in Critically Ill Patients.

Journal of Clinical Endocrinology and Metabolism, 2016
Paul Lee, C. Ng, A. Slattery, P. Nair, J. Eisman, J. Center   +5 more
semanticscholar   +1 more source